|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 2525789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11734283.2 |
| Date of filing the European patent application | 2011-01-19 | |
| (97) | Date of publication of the European application | 2012-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2011/000059 |
| Date | 2011-01-19 |
| (87) | Number | WO 2011/088553 |
| Date | 2011-07-28 |
| (30) | Number | Date | Country code |
| 2690488 | 2010-01-19 | CA |
| (72) |
LOPEZ, John , CA
DRAPER, Peter , CA
VASHISHTHA, Sankalp , CA
KLASSEN, Nancy , CA
ARMSTRONG, Christina , CA
|
| (73) |
Catalent Ontario Limited ,
2125 Ambassador Drive, Windsor, ON N9C 3R5,
CA
|
| (54) | PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF |
| PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF |